Actively Recruiting
A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy
Led by Sutter Health · Updated on 2025-05-15
30
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to assess whether Shengbai Oral Formula is a viable option for treatment of fatigue, pain, and neutropenia in patients undergoing their third cycle of chemotherapy.
CONDITIONS
Official Title
A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 80 years
- Diagnosed with cancer and scheduled for at least three chemotherapy cycles for curative or palliative treatment
- Chemotherapy administered at least every 2 weeks
- Completed radiation therapy at least 30 days ago
- Not pregnant and using contraception as recommended by clinician
- Life expectancy greater than 3 months
- Stable use of all herbal or complementary therapies for at least 30 days and agree not to add new ones during the study
- Baseline ECOG performance status of 2 or less
- Investigator’s opinion of likely compliance and ability to complete study and tests
You will not qualify if you...
- Elevated liver enzymes (ALT/AST) greater than 2.5 to 3 times normal range
- Estimated glomerular filtration rate (eGFR) less than 60
- Platelet count below 75,000
- Hemoglobin below 8.0
- Absolute neutrophil count below 1000
- History of bone marrow transplant
- Brain metastases or other cancer diagnoses except certain skin cancers
- Current seizure disorder
- New cardiac arrhythmias or recent heart attack
- Active infections like bacterial or viral infection, pneumonia, sepsis, gastric ulcers, nonhealing wounds, severe nausea/vomiting, diarrhea, or bleeding disorders
- Autoimmune diseases such as hyperthyroidism, lupus, or rheumatoid arthritis
- Current drug abuse disorder
- Participation in another clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sutter Health
Oakland, California, United States, 94609
Actively Recruiting
Research Team
J
Janet Han, BSN, RN
CONTACT
L
Leila Murray, BSN, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here